February 26, 2019

Secukinumab Associated With QoL Improvements in Pooled Psoriasis Data

According to pooled data from four Phase 3 studies, treatment with secukinumab (Cosentyx; Novartis) was associated with improvement in mobility, self-care, and usual activities (e.g., work, […]
February 22, 2019

Burden of Skin and Joint Symptoms Examined in Psoriatic Arthritis

Psoriatic arthritis and psoriasis were associated with significant decreases across multiple patient-reported outcomes, including quality of life and work productivity. In patients with concurrent psoriasis and psoriatic […]
February 20, 2019

New guidelines outline new treatment management for psoriasis

The guidelines released by the American Academy of Dermatology will for the first time provide comprehensive information to other physicians on how to treat patients beyond […]
February 15, 2019

Psoriasis treatment linked to improvement in heart disease 

Treatments for psoriasis could help prevent heart disease in patients with the skin condition, with patients having an 8 percent reduction in their risk. Anti-inflammatory biologic […]
February 8, 2019

Methotrexate More Effective In Psoriasis Patients Without Psoriatic Arthritis 

The immunosuppressive drug was more effective and resulted in fewer adverse events in patients with psoriasis but without psoriatic arthritis. A study of methotrexate in patients […]
January 31, 2019

People with Psoriasis More Likely to Develop Certain Gut Disorders

People with psoriasis may be at greater risk of developing certain gut disorders, a new study finds. People with psoriasis may be at greater risk of […]
January 24, 2019

Psoriasis and inflammatory bowel disease as one unit

Having psoriasis gives a patient a 1.75-fold increased odds of developing ulcerative colitis and a 1.70-fold increased odds of developing Crohn’s disease. Psoriasis and IBD (ulcerative colitis […]